Cargando…

P13. Intra-tumoral and surrogate immune responses in patients treated with the engineered anti-PD-L1 antibody (MPDL3280A)

Detalles Bibliográficos
Autores principales: Kowanetz, M, Vu, MT, Wu, J, Koeppen, H, Kohrt, H, Gettinger, S, Cruz, C, Denker, M, Chen, DS, Hegde, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072139/
http://dx.doi.org/10.1186/2051-1426-2-S2-P4
_version_ 1782322910579392512
author Kowanetz, M
Vu, MT
Wu, J
Koeppen, H
Kohrt, H
Gettinger, S
Cruz, C
Denker, M
Chen, DS
Hegde, P
author_facet Kowanetz, M
Vu, MT
Wu, J
Koeppen, H
Kohrt, H
Gettinger, S
Cruz, C
Denker, M
Chen, DS
Hegde, P
author_sort Kowanetz, M
collection PubMed
description
format Online
Article
Text
id pubmed-4072139
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40721392014-06-27 P13. Intra-tumoral and surrogate immune responses in patients treated with the engineered anti-PD-L1 antibody (MPDL3280A) Kowanetz, M Vu, MT Wu, J Koeppen, H Kohrt, H Gettinger, S Cruz, C Denker, M Chen, DS Hegde, P J Immunother Cancer Poster Presentation BioMed Central 2014-03-12 /pmc/articles/PMC4072139/ http://dx.doi.org/10.1186/2051-1426-2-S2-P4 Text en Copyright © 2014 Kowanetz et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Kowanetz, M
Vu, MT
Wu, J
Koeppen, H
Kohrt, H
Gettinger, S
Cruz, C
Denker, M
Chen, DS
Hegde, P
P13. Intra-tumoral and surrogate immune responses in patients treated with the engineered anti-PD-L1 antibody (MPDL3280A)
title P13. Intra-tumoral and surrogate immune responses in patients treated with the engineered anti-PD-L1 antibody (MPDL3280A)
title_full P13. Intra-tumoral and surrogate immune responses in patients treated with the engineered anti-PD-L1 antibody (MPDL3280A)
title_fullStr P13. Intra-tumoral and surrogate immune responses in patients treated with the engineered anti-PD-L1 antibody (MPDL3280A)
title_full_unstemmed P13. Intra-tumoral and surrogate immune responses in patients treated with the engineered anti-PD-L1 antibody (MPDL3280A)
title_short P13. Intra-tumoral and surrogate immune responses in patients treated with the engineered anti-PD-L1 antibody (MPDL3280A)
title_sort p13. intra-tumoral and surrogate immune responses in patients treated with the engineered anti-pd-l1 antibody (mpdl3280a)
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072139/
http://dx.doi.org/10.1186/2051-1426-2-S2-P4
work_keys_str_mv AT kowanetzm p13intratumoralandsurrogateimmuneresponsesinpatientstreatedwiththeengineeredantipdl1antibodympdl3280a
AT vumt p13intratumoralandsurrogateimmuneresponsesinpatientstreatedwiththeengineeredantipdl1antibodympdl3280a
AT wuj p13intratumoralandsurrogateimmuneresponsesinpatientstreatedwiththeengineeredantipdl1antibodympdl3280a
AT koeppenh p13intratumoralandsurrogateimmuneresponsesinpatientstreatedwiththeengineeredantipdl1antibodympdl3280a
AT kohrth p13intratumoralandsurrogateimmuneresponsesinpatientstreatedwiththeengineeredantipdl1antibodympdl3280a
AT gettingers p13intratumoralandsurrogateimmuneresponsesinpatientstreatedwiththeengineeredantipdl1antibodympdl3280a
AT cruzc p13intratumoralandsurrogateimmuneresponsesinpatientstreatedwiththeengineeredantipdl1antibodympdl3280a
AT denkerm p13intratumoralandsurrogateimmuneresponsesinpatientstreatedwiththeengineeredantipdl1antibodympdl3280a
AT chends p13intratumoralandsurrogateimmuneresponsesinpatientstreatedwiththeengineeredantipdl1antibodympdl3280a
AT hegdep p13intratumoralandsurrogateimmuneresponsesinpatientstreatedwiththeengineeredantipdl1antibodympdl3280a